ICML 2017 | Immunotherapy highlights from ICML 2017
David Maloney, MD, PhD from the Fred Hutchinson Cancer Center, Seattle, WA provides an overview of the immunotherapy highlights from the International Conference on Malignant Lymphoma (ICML) 2017 held in Lugano, Switzerland. Dr Maloney describes the latest data presented on immunotherapy treatments in lymphoma, including CAR-T cell therapy and checkpoint inhibitor antibodies. Explaining the advances in the field of immunotherapy as well as the challenges, Dr Maloney discusses the approval of future novel treatments. With regards to the impact on patients, Dr Maloney assesses the risk to benefit ratio for patients receiving immunotherapy.
Get great new content delivered to your inboxSign up